Tandem Diabetes Care | TNDM - Interest Expense On Debt


Tandem Diabetes Care reported $2.07M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
Accuray USD 2.88M 72K Dec/2024
Align Technology USD 2M 660K Mar/2023
AtriCure USD 1.33M 17K Sep/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 3M Dec/2025
Cooper Companies USD 22.4M 2M Dec/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Globus Medical USD 17K 5.1B Dec/2025
ICU Medical USD 20.64M 21.39M Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
Intuitive Surgical USD 19.35B 811.4M Sep/2025
J&J USD 18M 290M Sep/2025
Masimo USD 7.5M 1.3M Dec/2025
Medtronic USD 181M 0 Dec/2025
Merit Medical Systems USD 6.36M 390K Dec/2025
Orthofix International 4.68M 731K Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
Stryker USD 157M 46.17B Sep/2025
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 28.15M 3.69M Dec/2025
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025